Objective To assess whether trends in mortality from heart failure (HF) in Australia are due to a change in awareness of the condition or real changes in its epidemiology. Methods We carried out a retrospective analysis of official data on national mortality data between 1997 and 2003. A death was attributed to HF if the death certificate mentioned HF as either the underlying cause of death (UCD) or among the contributory factors.
Introduction
Heart failure (HF) is a disabling chronic disease and a major cause of morbidi i ity and mortality among older adults. 1 Despite its being a significant burden on healthicare systems, especially with recent improvements in survival of patients with HF, [2] [3] [4] the epidemiology of HF is incomi i pletely understood. There are numbers of reports referring to an "epidemic" of HF in developed countries. [5] [6] [7] [8] However, recent declines in incidence, case fatality and mortality from major antecedents of HF, ischaemic heart disease (IHD) and hypertensive heart disease, suggest that the incidence and mortality of HF might also be changing. 3, [9] [10] [11] Untangling this conundrum requires careful investii i gation of the relevant epidemiological indices of HF.
In countries with complete vital registration, mortality data can provide valuable information on the epidemioli i ogy of HF. While many studies have used data on the single underlying cause of death (UCD) given in official statistics to estimate the mortality from particular 
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diseases, [12] [13] [14] [15] this strategy can underesi i timate mortality associated with some conditions such as HF that are regarded as a "mode of death" rather than an uni i derlying "cause of death". 16 For example, in Australia in 2002, HF was the official cause of only 2% (2729) of all deaths, 17 which appears to be inconsistent with firstiyear case fatality for HF of 24-28% and an estimated incidence of 30 000 cases per year. 3, 17 There are additional problems rei i lated to use of mortality statistics for conditions whose incidence rises sharply with increasing age. The presence of sevi i eral chronic conditions in many elderly individuals makes it difficult to identify the exact single UCD. Thus, even where medical certification of cause of death is universal, three factors complicate the use of official mortality statistics to study trends in HF. These are: lack of precii i sion in the diagnosis, certification rules about not ascribing fatalities to a "mode of death", and the presence of multiple coimorbidities.
The study of trends in mortality is potentially complicated by the change from the 9th to the 10th revision of the International classification of diseases (ICD) in the late 1990s, and perhaps also by the adoption of new diagnostic criteria for acute myocardial infarction, which could influence clinical percepi i tions as to which individuals are at special risk of developing HF.
Complete death registration and certification of all deaths by a medical practitioner facilitate the study of mori i tality as one of the main epidemiological features of HF in Australia. Furthermore, recording and coding, within official mortality data, of multiple conditions contributing to death provides an imi i portant opportunity to examine not only trends in HF as the UCD, but also in the proportion of all deaths to which HF is believed to have contributed and in other conditions that might "compete" with HF for identification as the UCD. This paper presents a detailed examination of HF as the single cause of death and as a contributor to all deaths in Australia in 1997-2003, when all deaths were coded using ICDi10, to determine whether 
Measurement of HF-related mortality and other associated causes
Australia has used ICDi10 to classify mortality data since 1997. In the presi i ent study a death was defined as involvi i ing HF if at least one of the causes of death was coded to any of the following ten rubrics: hypertensive heart disease with congestive heart failure (I11.0), hypertensive heart and renal disease with congestive heart failure (I13.0), hyi i pertensive heart and renal disease with heart failure and renal failure (I13.2), ischaemic cardiomyopathy (I25.5), chronic constrictive pericarditis (I31.1), dilated cardiomyopathy (I42.0), alcoi i holic cardiomyopathy (I42.6), congesi i tive heart failure (I50.0), left ventricular heart failure (I50.1), or heart failure, unspecified (I50.9). In addition, to find other conditions associated with HF either as the UCD or as a contributory factor, we identified all mortality records mentioning IHD and circulatory disease as defined by the relevant chapter of ICDi10.
Statistical analysis
The data were analysed using Stata version 8. 19 We calculated agei and sexi specific mortality rates for HF for each year by dividing the number of deaths attributed to HF by the relevant popui i lation during that year. Mortality rates were standardized using the "European" population, 20 treating people aged less than 60 years and 85 years and older as single groups, and employing 5iyear age groups to age 85 years. We calculated the mortality rate for HF as the UCD or where HF was mentioned anywhere on the death certificate separately for each year. We estimated trends for both mortality rates and crude total numbers of deaths associated with HF and calcui i lated changes relative to levels in the first year of study.
In order to investigate the extent to which changes in certification or coding practice may have contributed to changes in mortality from HF, we examined trends in other diagnoses associated with HF in two ways. First, we examined the proportion of deaths ascribed to IHD and other circulatory disease in which there was mention of HF. Second, among deaths assigned to HF as UCD, we exi i amined the proportion with mentions of IHD or other circulatory disease. We also examined the trend in the propori i tion of all deaths from circulatory disease and of all deaths that had mention of HF on the death certificate.
Results
In 1997, the total numbers of deaths ati i tributed to HF as UCD or mentioned anywhere on the death certificate were 4667 and 20 614, respectively ( 
Mortality rates
The overall ageistandardized mortality rates for HF as UCD or mentioned anyi i where were 17.1 and 78.8 per 100 000 personiyears, respectively. Mortality rates for HF rose sharply with age (Table 2) , but decreased in all age groups and both sexes over the study period, such that agei standardized rates for HF as UCD fell by 38% and 39% in men and women, respectively ( Table 1 ). The decreases were inversely related to age and were least in men and women aged 85 and older (1.3% and 5.7%, respectively). The ageistandardized mortality rate was higher in men than in women. This was true for HF either as the UCD or
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Farid Najafi et al. when it was mentioned anywhere on the certificate, but the excess in males decreased with increasing age such that, among people aged 85 years and older, mortality from HF as UCD was higher in women than in men ( 
Relationship between deaths from HF, IHD and circulatory disease
In 1997, 24.8% and 18.3% of all deaths attributed to IHD and circulatory disease mentioned HF as a contributory factor (Fig. 2) . These proportions remained stable over the period of study, and were 24.1% and 17.3%, respectively, in 2003.
IHD was mentioned on only 2.8% of certificates nominating HF as the UCD. The corresponding proportion for other circulatory disease was 36.3%. Neither of these proportions changed markedly over the period of study.
Discussion
This study shows a large decline in the mortality rate for HF in Australia since 1997. Several factors suggest that this decline is real and not an artefact arising from changes in writing or coding death certificates. These include the magnitude of the change (38% in 7 years), the uni i changing contribution of HF to total cardiovascular mortality, the unchangi i ing proportions of deaths from IHD and circulatory disease with mention of HF, and the very small decreases in HF relative to total mortality. Rule 3 of ICDi10 specifies that HF should not be recorded as the UCD. Thus, at least some of the deaths ascribed by the certifying doctors to HF will be officially allocated to other conditions such as IHD by the specialist nosoloi i gist coding death certificates. However, our data showing no changes in the proportions of deaths from IHD and circulatory disease with mention of HF as a contributory cause suggest that the extent of reassignment of deaths initially ascribed to HF has not changed over the study period. Thus, change in coding practice is very unlikely to have made a major contribution to the decline in mortality from HF that we observed. The unchanged relationship of HF to total mortality from circulatory disease adds further support to this conclusion.
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However, imprecise use of epidemiologii i cal terms is contributing to the confui i sion about the speed and direction of changes in HF. For example, there is a need to distinguish between "incidence", meaning new cases of HF in a specific period, and "caseiload", meaning the count of prevalent cases. The caseiload partly reflects the size of the population at risk, which is increasing as the popui i lation ages. Therefore the caseiload can increase while incidence is stable or even falling. HF may have become relatively more prominent in cardiologists' work because of increased diagnostic activity due to changes in techniques of investii i gation, or the advent of more effective therapies that extend survival of patients with HF, or because other conditions are becoming less common. Claims that we are in the midst of an "epidemic of heart failure" 5 therefore need to be examined critically.
Apart from changes in the prepai i ration and classification of death ceri i tificates (discussed above and seen to be unlikely as a cause of the observed decrease), several other factors affect deaths from HF. As mortality from HF is strongly related to age, the increase in the Australian population aged 75 years and older from 5.1% in 1997 to 6.0% in 2003 might have been expected to precipitate an increase in absolute numbers of deaths from HF, but in fact these decreased over the study period. At the same time, the continuing decline in incidence of IHD 21 and better care for this condition might have resulted in a decrease in incident cases of HF. 22, 23 Thus, a decline in the incidence and even the populationiwide prevalence of HF is one possible explanation for the observed decline in mortality from HF.
Another possible explanation for observed trends is better care for HF patients. 24 Despite continuing underutii i lization of effective treatment in patients suffering from HF (such as angiotensini converting enzyme inhibitors, betai blockers, warfarin and angiotensiniII antagonists), 25 earlier diagnosis of HF (as a result of increased use of diagnostic procedures) and increasing use of proven treatments 26, 27 should have lengthened survival of affected patients. This would increase the period in which competing causes of death could exact their toll. However, without detailed information on the magnitude of each of these effects, it is difficult to quantify the contribution of such factors to the observed decline in mortality from HF in Australia.
The results of this study are consisi i tent with previous reports on mortality from HF in Australia that indicate a downward trend from 1981, although these studies were based on analysis of UCD alone. 17, 28 While studies in Canada and the USA did not show consistent results, 13, 15 mortality from HF has been falling in England, Scotland and Spain. 12, 29, 30 These trends are based on ageistandardized mortality rates and therefore will not be distorted by changes in the age structure of the relevant populations.
Except for the studies in Scotland and England that identified HF meni i tioned anywhere on the death ceri i tificates, all previous reports have been based on HF as UCD. Consequently, in addition to underestimating the real contribution of HF to mortality, variai i tion in selection and recording of HF as the UCD in different countries and periods might produce some systematic errors. 31 Furthermore, all of those studies were conducted before 1997 and emi i ployed ICDi9. The increasing use of echocardiography for diagnosis of HF since 1997 potentially affords greater diagnostic precision, but may have ini i creased the caseiload of diagnosed cases, while possibly also decreasing their averi i age severity. On the other hand, many international studies in the 1990s rei i ported considerable underutilization of angiotensiniconverting enzyme inhibii i tors, betaiblockers, and warfarin, which would have contributed to an avoidably high case fatality in HF.
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Study limitations
Official mortality statistics are open to artefacts related to changes in diagnosi i tic practice and technology concerning particular conditions, customs for the completion of death certificates, and use of new systems and rules for selecti i ing and recording the single UCD. In addition, diagnoses of HF might vary systematically between different popui i lations, doctors and sets of diagnostic criteria, which may preclude generali i ization of our estimated rates to other countries. 35, 36 However, these potential Proportion of deaths from ischaemic heart disease with other mention of heart failure on death certificate
Proportion of deaths from circulatory disease with mention of heart failure on death certificate
Proportion of deaths from heart failure as UCD with mention of ischaemic heart disease on death certificate difficulties probably do not affect the trends we observed during the period studied. As Australia has complete death registration with certification by medical practitioners or coroners, official data on Australian mortality are regarded as being of high quality. 37 Our data allow us to rule out a shift away from HF to other cardiovascular conditions in the recording and coding of deaths as the explanation for the decrease in mortali i ity from HF that we have documented. They also relate to a period in which a single system of classification was used to identify and code the UCD.
Conclusion
We have demonstrated a major decline in mortality from HF in Australia over recent years. Rather than being an artei i fact related to changes in certification of death or coding the death certificates, this decline is likely to reflect a real change in the epidemiology of HF. A prospective populationibased cohort study would help to determine whether this trend reflects primarily a decline in the incidence of HF, reflecting a decrease in the incidence of IHD, or improved care of patients with IHD, or better management of established HF and reduced caseifatality in this condition. O
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